The biotech is developing an experimental drug for the most common of a family of disorders all caused by errors in ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Bristol-Myers Squibb (BMY – Research Report) and ...

After several weeks and thousands of votes, TV drug ads from Apellis Pharmaceuticals and AstraZeneca found themselves in the ...

BioHarvest Sciences Inc. BHST shares ended the last trading session 5.2% higher at $5.90. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on IDEAYA Biosciences (IDYA – Research Report) today and set a price target ...

Biotech leaders urge Senate intervention as FDA restructuring risks expertise loss impacting operations. Read more here.